SHL Medical is excited to announce our participation for the first time ever in the 2022 CPHI Frankfurt
Menu
SHL Medical will be exhibiting at the 2022 PODD® conference
SHL Medical is excited to announce its return in-person to the 2022 PDA
SHL Medical will participate for the first time in Pharma 2022.
In the August of ONdrug Delivery, SHL Medical Head of Continuous Improvement Tracy Pedreso explains how championing lean manufacturing and business excellence can maximize lasting value for pharmaceutical companies and their patients.
SHL’s Taras Seniuch and Amy Hartl, discuss the importance of design transfer in the development of combination product autoinjectors.
SHL will exhibit at the 2022 Prefilled Syringe Seminar (PFSS) Tokyo organized by Parenteral Drug Association (PDA) Japan.
SHL Medical (hereinafter referred to as “SHL”) has revealed plans for a new manufacturing site in the US, in response to the growing market demand for its autoinjector product portfolio. The decision stems from SHL’s strategic assessments in extending its production to North America.
To support the development of rapidly implementable and holistic approaches to CO2 reduction in the industrial environment, SHL Medical has joined the “Association for the Decarbonization of Industries”. The recently founded association focuses on new hydrogen production processes for the decarbonization of industrial high-temperature processes and logistics.
